Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.
Yao KX, Lyu H, Liao MH, Yang L, Gao YP, Liu QB, Wang CK, Lu YM, Jiang GJ, Han F, Wang P.
Yao KX, et al.
Sci Rep. 2019 Dec 3;9(1):18248. doi: 10.1038/s41598-019-47868-0.
Sci Rep. 2019.
PMID: 31796756
Free PMC article.
Oral administration of levamlodipine besylate (0.1 mg/kg) could reduce the latency to find the hidden platform in the MWM test as compared to the vehicle group. Furthermore, vehicle-treated mice revealed reduced phospho-CaMKII (Thr286) levels in the hippocampus, which can …
Oral administration of levamlodipine besylate (0.1 mg/kg) could reduce the latency to find the hidden platform in the MWM test as com …